Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MAVACAMTEN vs MEBENDAZOLE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

MAVACAMTEN vs MEBENDAZOLE: Safety Overview

Metric MAVACAMTEN MEBENDAZOLE
Total FAERS Reports 3,250 440
Deaths Reported 79 28
Death Rate 2.4% 6.4%
Hospitalizations 454 70
Average Patient Age 66.6 yrs 29.5 yrs
% Female Patients 69.1% 68.4%
FDA Approval Date Apr 28, 2022 Approved Prior to Jan 1, 1982
Manufacturer Myokardia, Inc. Janssen Pharmaceuticals, Inc.
Route ORAL ORAL
Marketing Status Prescription Discontinued